| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2877119 | The Annals of Thoracic Surgery | 2011 | 5 Pages |
Abstract
A lung progenitor cell signature predicts poor prognosis in lung adenocarcinoma. Modulation of these genes or their signaling pathways may be effective therapeutic strategies in the future.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Mark MD, Thomas A. MD, Cheryl P. BS, Justin PhD, David H. MD, Emma L. PhD,